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Abstract
Background: Birth weight, a marker of the intrauterine environment, has been extensively studied in
epidemiological research in relation to subsequent health and disease. Although numerous meta-analyses have
been published examining the association between birth weight and subsequent health-related outcomes, the
epidemiological credibility of these associations has not been thoroughly assessed. The objective of this study is to
map the diverse health outcomes associated with birth weight and evaluate the credibility and presence of biases
in the reported associations.
Methods: An umbrella review was performed to identify systematic reviews and meta-analyses of observational
studies investigating the association between birth weight and subsequent health outcomes and traits. For each
association, we estimated the summary effect size by random-effects and fixed-effects models, the 95 % confidence
interval, and the 95 % prediction interval. We also assessed the between-study heterogeneity, evidence for small-
study effects and excess significance bias. We further applied standardized methodological criteria to evaluate the
epidemiological credibility of the statistically significant associations.
Results: Thirty-nine articles including 78 associations between birth weight and diverse outcomes met the eligibility
criteria. A wide range of health outcomes has been studied, ranging from anthropometry and metabolic diseases,
cardiovascular diseases and cardiovascular risk factors, various cancers, respiratory diseases and allergies, musculoskeletal
traits and perinatal outcomes. Forty-seven of 78 associations presented a nominally significant summary effect and 21
associations remained statistically significant at P < 1 × 10−6. Thirty associations presented large or very large between-
study heterogeneity. Evidence for small-study effects and excess significance bias was present in 13 and 16 associations,
respectively. One association with low birth weight (increased risk for all-cause mortality), two dose-response associations
with birth weight (higher bone mineral concentration in hip and lower risk for mortality from cardiovascular diseases per
1 kg increase in birth weight) and one association with small-for-gestational age infants with normal birth weight
(increased risk for childhood stunting) presented convincing evidence. Eleven additional associations had highly
suggestive evidence.
Conclusions: The range of outcomes convincingly associated with birth weight might be narrower than originally
described under the “fetal origin hypothesis” of disease. There is weak evidence that birth weight constitutes an effective
public health intervention marker.
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Background
In early 1990’s, the “fetal origin hypothesis” of adult dis-
eases was suggested to describe the observed associations
between low birth weight (BW) and cardiovascular dis-
eases in adult life [1–5]. Barker, who first observed these
associations, hypothesized that fetal under-nutrition may
lead to disproportionate fetal growth and program later
coronary heart disease risk [6].
Since then, the importance of the early life and intra-
uterine environment in relation to later disease has been
widely acknowledged and studied [1, 6–10]. BW is consid-
ered a marker of the intrauterine environment and has
been extensively studied in epidemiological research, both
in terms of its predictors but mainly in relation to su-
bsequent disease. The examined phenotypes expanded be-
yond cardiovascular conditions into a wide range of
outcomes and traits, including respiratory disease [8, 11],
cancer [12, 13] and psychiatric outcomes [14]. At the same
time, acknowledging its importance, WHO included low
BW (<2500 g) as one of its 2025 targets, namely a 30 % re-
duction in the number of infants born with a BW below
2500 g by 2025 [15]. During the last two decades, interest
in the potential health risks associated with high BW
(>4000 g) has also emerged, and associations between high
BW and the risk of adverse health outcomes have been
studied in an increasing number of scientific papers.
Interpreting associations between BW and the occur-
rence of health problems later in life is, however, challen-
ging and linked to a series of methodological limitations
[16]. Despite the attention that BW has received in public
health policy and epidemiological research, a comprehen-
sive assessment of the proposed associations between BW
and future disease is lacking. In the current study, we ap-
plied the methodology of umbrella reviews to map all the
outcomes that have been associated with low and high
BW and we applied a standardized approach to assess the
credibility of the findings in order to identify which associ-
ations are supported by robust evidence.
Methods
Literature search and eligibility criteria
We performed an umbrella review, which is a compre-
hensive and systematic collection and evaluation of mul-
tiple systematic reviews and meta-analyses performed on
a specific research topic [17]. We followed a standard-
ized procedure that has already been applied in the ap-
praisal of observational associations in other research
fields [18–21]. We systematically searched PubMed from
inception to December 24, 2015, to identify systematic
reviews and meta-analyses of observational studies
examining associations of BW with medical conditions,
traits and biomarkers. We used the following search al-
gorithm: (“birth weight” OR “birth size” OR “small for
gestational age” OR “large for gestational age” OR “fetal
growth restriction” OR “intra-uterine growth restriction”)
AND (systematic review* OR systematic literature review*
OR meta-analys*). We excluded meta-analyses examining
genetic or environmental determinants of BW. We further
excluded the meta-analyses of individual participant data
that did not report the study-specific estimates and pooled
analyses that only summarized evidence across a non-
systematically selected number of cohort studies or that
did not present the study-specific effect estimates of com-
ponent studies [22–27]. We did not apply any limitation
based on language of publication.
Data extraction
Two independent researchers extracted the data (LB,
CK), and in the case of discrepancies, the final decision
was that of a third researcher (IT). From each eligible
article, we recorded the first author, journal, year of pub-
lication, examined outcomes and number of studies in-
cluded. We also extracted the study-specific effect sizes
(risk ratio, odds ratio, hazard ratio, mean difference and
regression coefficient) along with the corresponding
95 % confidence intervals and the number of cases and
controls in each study for each association. Whenever
the sample sizes were not available through the meta-
analysis, we retrieved the original reports to record
them. Further, when multiple comparisons were avail-
able for a particular phenotype (e.g. < 2500 g vs. ≥
2500 g and < 2500 g vs. 2500–4000 g) we always pre-
ferred to extract information on < 2500 g versus ≥ 2500 g
and > 4000 g versus ≤ 4000 g in the case of low BW and
high BW, respectively. However, when this comparison
was not available, we extracted the comparison reported
by the meta-analysis. For the excluded meta-analyses
assessing an overlapping association, we recorded the
level of comparison and the summary effect estimate
along with the 95 % confidence interval. Additionally,
we scrutinized the full-text of the eligible papers to
examine whether their authors discussed the potential
effect of gestational age in the association of BW with
subsequent health outcomes.
Statistical analysis
For each meta-analysis, we estimated the summary effect
size and its 95 % confidence interval with both fixed-
effects and random-effects models [28, 29]. We also
estimated the 95 % prediction interval, which further ac-
counts for between-study heterogeneity and evaluates the
uncertainty for the effect that would be expected in a new
study addressing that same association [30, 31].
In the case of meta-analyses with continuous out-
comes, the standardized mean difference was trans-
formed to an odds ratio with an established formula
[32]. Between-study heterogeneity was assessed by the I2
metric [33]. I2 ranges between 0 % and 100 % and is the
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ratio of between-study variance over the sum of the
within-study and between-study variances [34]. Values
exceeding 50 % or 75 % are usually judged to represent
large or very large heterogeneity, respectively.
We assessed whether there was evidence for small-
study effects (i.e. whether smaller studies tend to give
substantially larger estimates of effect size compared
with larger studies) with the regression asymmetry test
proposed by Egger et al. [35, 36]. A P value less than
0.10 with a more conservative effect in the largest study
than in random-effects meta-analysis was judged to be
evidence for small-study effects.
We applied the excess statistical significance test,
which assesses whether the observed number of studies
with nominally significant results is larger than their
expected number [37]. This test assesses whether the
number of positive studies among those in a meta-
analysis is too large based on the power that these stud-
ies have to detect plausible effects at an α of 0.05. The
expected number of studies with significant results is
calculated in each meta-analysis by the sum of the stat-
istical power estimates for each component study. The
power of each component study was estimated using
the effect size of the largest study (smallest SE) in a
meta-analysis and the power calculation was based on
an algorithm using a non-central t distribution [38, 39].
Excess statistical significance for single meta-analyses
was claimed at P < 0.10 [37]. For four associations, the
power calculations and the excess statistical significance
test were not performed, because the sample sizes of
the component studies could not be retrieved neither
from meta-analysis papers nor from the original
reports.
Finally, we identified the associations that had the
strongest validity and were not suggestive of bias. Spe-
cifically, we considered as convincing the associations
that met the following criteria: significance under the
random-effects model at P < 1 × 10−6, more than 1000
cases, not large between-study heterogeneity (I2 <
50 %), 95 % prediction interval excluding the null value,
and no evidence of small-study effects and excess sig-
nificance bias. Additionally, the associations with a sta-
tistically significant effect at P < 1 × 10−6, more than
1000 cases, and a statistically significant effect in the
largest study were characterized as having highly sug-
gestive evidence. We considered as suggestive the asso-
ciations that have more than 1000 cases and a
statistically significant effect under the random-effects
model at P < 1 × 10−3. The rest of statistically significant
associations at P < 0.05 under random-effects model
were graded as weak associations.
The statistical analyses were performed with STATA
version 12.0 and the power calculations were performed
using STATA version 12.0 and G*Power version 3.1.
Results
Overall, the literature search identified 1520 articles, of
which 39 articles, published between 2005 and 2015,
were deemed eligible (Fig. 1). Sixty-three papers were
screened by full-text. Of these, 10 examined the same or
related phenotypes in the same population (defined as
overlapping meta-analysis), six were individual partici-
pant data meta-analyses that did not report the study-
specific effect estimates, and 12 were systematic reviews
without a quantitative synthesis. The 39 eligible papers
included 78 different meta-analyses (Table 1): 28 asses-
sing low BW, four assessing small-for-gestational age in-
fants, 18 assessing high BW, and 28 assessing a dose–
response association between BW and subsequent health
outcomes. A wide range of health outcomes has been
studied ranging from anthropometry and metabolic dis-
ease, cardiovascular disease and cardiovascular risk fac-
tors, various cancers, respiratory diseases and allergies,
musculoskeletal traits, and perinatal outcomes. Both
neonatal and childhood conditions as well as adult dis-
eases have been extensively examined (Table 1). Only
two eligible papers had access to raw data of primary
studies and performed an individual-level data meta-
analysis [8, 40].
Overall, we identified more than one published meta-
analysis for 25 outcomes, i.e. meta-analysis examining
the same exposure (birth weight) and the same outcome.
Overlapping meta-analyses provided concordant results,
with the exception of two pairs, which had a summary
effect in opposite direction (diastolic blood pressure and
overweight) compared to the meta-analysis included in
our umbrella review (largest most recently published
meta-analysis). Six other meta-analyses differed in the
summary effect significance compared to the most re-
cent one (Additional file 1: Table S1).
Associations with low BW
Across 28 meta-analyses examining low BW as a dichot-
omous trait, the median number of cases was 5766
(interquartile range (IQR), 1574–11,729), while the me-
dian number of datasets was 11 (IQR, 8–16). Overall, 21
out of 28 associations had more than 1000 cases, 17 of
28 meta-analyses presented a nominally significant effect
(P < 0.05) and 10 of them had a significant effect at P <
0.001. Only seven meta-analyses, examining the associ-
ation of low BW with perinatal mortality in developing
countries, wheezing disorders in childhood, being over-
weight or obese in adulthood, coronary heart disease,
intelligence in adolescence, all-cause mortality, and
chronic kidney disease, were statistically significant at P
< 1 × 10−6 under the random-effects model (Table 1).
The largest study had a standard error of less than 0.10
in 17 meta-analyses and a more conservative effect com-
pared to random-effects model in 15 meta-analyses.
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Four meta-analyses (perinatal mortality in developing
countries, coronary heart disease, school-age asthma, all-
cause mortality) had a 95 % prediction interval excluding
the null value. Five associations had large heterogeneity
estimates (I2 ≥ 50 % and I2 ≤ 75 %), and 10 associations
had very large heterogeneity estimates (I2 > 75 %). On bias
assessment, seven associations had evidence for small-
study effects (chronic kidney disease, coronary heart
disease, diastolic blood pressure, intelligence in adoles-
cence, medulloblastoma, wheezing disorders in child-
hood, and being overweight or obese in adulthood), and
four associations (chronic kidney disease, diastolic
blood pressure, intelligence in adolescence, and tes-
ticular cancer) had hints for excess significance bias
(Table 1, Additional file 2: Table S2).
Associations with high BW
Across 18 meta-analyses examining high BW as a di-
chotomous trait, the median number of cases was 6115
(IQR, 3153–10,642), 16 meta-analyses were supported
by more than 1000 cases, and the median number of
datasets was 10 (IQR, 8–14). Ten associations presented
a significant effect at P < 0.05, but only three associations
(acute lymphoblastic leukaemia, all types of leukaemia,
and being overweight or obese in adulthood) remained
statistically significant after the application of a more
conservative significance threshold (P < 1 × 10−6). The
largest study had a standard error of less than 0.10 in
four meta-analyses and a more conservative effect com-
pared to random-effects model in 12 meta-analyses.
Only four meta-analyses (all types of leukaemia, neuro-
blastoma, type 1 diabetes mellitus, and being overweight
or obese in adulthood) had a 95 % prediction interval
excluding the null value (Table 1). The heterogeneity es-
timate was large (I2 ≥ 50 % and I2 ≤ 75 %) in seven meta-
analyses and only one meta-analysis presented very large
heterogeneity (I2 > 75 %). Two associations presented
hints for both small-study effects and excess significance
1,520 articles reviewed 
by title screening
142 articles reviewed by 
abstract screening
39 eligible articles published until 
December 24, 2015
67 articles reviewed by 
full text screening
1,378 articles were excluded 
578 were treatment studies
487 examined other research topics 
274 were editorials or narrative reviews
29 were articles about genetic epidemiology
6 were articles about health economics
4 were methodological papers
75 articles were excluded
74 examined other research topics
1 was treatment study
28 articles were excluded
12 were systematic reviews without a quantitative 
synthesis
10 were not the largest meta-analysis investigating an 
association
6 were individual participant data meta-analyses
Fig. 1 Flow chart of literature search
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Table 1 Quantitative synthesis, bias assessment and credibility assessment of 74 associations between different comparisons of birth weight and health outcomes or traits
Reference Outcome Level of
comparison
N cases/
N controls
N
datasets
Effect size
metric
Random-effects meta-
analysis (95 % CI)
P value
(random)
I2 95 %
prediction
intervals
P value for
Egger test
P value for Excess
significance test
Araujo de
Franca, 2014
[59]
Waist circumference Per 1 kg
increase
4898d 6 Regression
coefficient
−0.10 (−0.73 to 0.53) 0.760 73.2 −2.04 to 1.84 0.725 0.943
Araujo de
Franca, 2014
[59]
Waist-to-hip ratio Per 1 kg
increase
5008d 10 Regression
coefficient
−0.59 (−0.84 to −0.34) 4.0 × 10−6 0 −0.89 to
−0.30
0.545 0.052
Baird, 2011 [48] BMC in hip Per 1 kg
increase
1795d 6 Regression
coefficient
1.42 (0.90 to 1.94) 8.3 × 10−8 5.9 0.56 to 2.28 0.584 0.838
Baird, 2011 [48] BMC in lumbar spine Per 1 kg
increase
3181d 7 Regression
coefficient
1.72 (0.76 to 2.67) 4.2 × 10−4 33.5 −0.53 to 3.97 0.069a 1.6 × 10−4
Baird, 2011 [48] BMD in hip Per 1 kg
increase
3188d 7 Regression
coefficient
0.01 (0.00 to 0.02) 0.235 0 −0.01 to 0.01 0.708 0.271
Baird, 2011 [48] BMD in lumbar spine Per 1 kg
increase
3506d 8 Regression
coefficient
0.00 (−0.01 to 0.01) 0.779 14.9 −0.02 to 0.02 0.831 0.341
Berhan, 2014
[46]
Perinatal mortality in
developing countries
<2500 g vs.
≥ 2500 g
21,184/
285,970
14 OR 9.59 (6.11 to 15.04) 7.5 × 10−23 98.9 1.43 to 64.18 0.954 0.707
Caughey, 2009
[13]
Acute lymphoblastic
leukaemia
<2500 g vs.
≥ 2500 g
4805/
765,827
10 RR 0.97 (0.81 to 1.16) 0.736 0 0.78 to 1.20 0.289 NP
Caughey, 2009
[13]
Acute lymphoblastic
leukaemia
>4000 g vs.
≤ 4000 g
11,082/
2,228,906
23 RR 1.29 (1.17 to 1.42) 1.9 × 10−7 36.3 0.97 to 1.72 0.055a 9.4 × 10−7
Caughey, 2009
[13]
Acute lymphoblastic
leukaemia
Per 1 kg
increase
7404/
858,650
16 RR 1.19 (1.10 to 1.28) 1.7 × 10−5 54.7 0.93 to 1.52 0.990 2.2 × 10−4
Caughey, 2009
[13]
All types of leukaemia <2500 g vs.
≥ 2500 g
5766/
766,202
11 RR 1.04 (0.86 to 1.26) 0.683 10 0.76 to 1.43 0.357 NP
Caughey, 2009
[13]
All types of leukaemia >4000 g vs.
≤ 4000 g
NA/NA 14 RR 1.42 (1.26 to 1.60) 1.2 × 10−8 28.5 1.07 to 1.88 0.001a NA
Caughey, 2009
[13]
All types of leukaemia Per 1 kg
increase
11,313/
861,710
21 RR 1.19 (1.12 to 1.27) 5.1 × 10−8 45.3 0.97 to 1.45 0.590 0.001
Caughey, 2009
[13]
Acute myeloid
leukaemia
<2500 g vs.
≥ 2500 g
756/
851,204
9 RR 1.46 (0.87 to 2.43) 0.151 43.7 0.39 to 5.43 0.606 NP
Caughey, 2009
[13]
Acute myeloid
leukaemia
>4000 g vs.
≤ 4000 g
756/
851,204
9 RR 1.25 (1.09 to 1.43) 1.3 × 10−3 43.9 0.88 to 1.77 0.216 3.1 × 10−4
Chen, 2012 [60] Bone tumour >4000 g vs.
NBW
4044/
272,354
8 OR 1.21 (0.97 to 1.50) 0.091 37.8 0.71 to 2.03 0.093a 0.396
Christian, 2013
[40]
Childhood stunting SGA vs. AGA
(BW ≥ 2500 g)
5413/
16,663
10 OR 1.92 (1.75 to 2.12) 1.1 × 10−41 0 1.72 to 2.15 0.968 NP
Christian, 2013
[40]
Childhood stunting SGA vs. AGA
(BW < 2500 g)
843/1171 10 OR 3.00 (2.36 to 3.81) 2.3 × 10−19 56.6 1.53 to 5.85 0.555 NP
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Table 1 Quantitative synthesis, bias assessment and credibility assessment of 74 associations between different comparisons of birth weight and health outcomes or traits
(Continued)
Cook, 2010 [58] Testicular cancer <2500 g vs.
NBW
6906/
612,741
17 OR 1.34 (1.08 to 1.67) 7.9 × 10−3 50.9 0.69 to 2.62 0.135 0.049
Davey-Smith,
2007 [61]
Maternal cardiovascular
mortality
Per 1 SD
increase
2976/
974,667
6 HR 0.75 (0.67 to 0.84) 3.1 × 10−7 79.8 0.53 to 1.06 0.657 0.119
Davey-Smith,
2007 [61]
Paternal cardiovascular
mortality
Per 1 SD
increase
9375/
774,325
3 HR 0.93 (0.91 to 0.95) 2.0 × 10−9 0 0.80 to 1.09 0.317 0.516
der Voort, 2014
[8]
Pre-school wheezing <2500 g vs.
NBW
40,603/
103,271
26 OR 1.10 (1.00 to 1.21) 0.051 16 0.89 to 1.36 0.829 NP
der Voort, 2014
[8]
School-age asthma <2500 g vs.
NBW
11,729/
121,198
16 OR 1.13 (1.01 to 1.27) 0.032 0 1.00 to 1.28 0.639 NP
Dodds, 2012
[62]
Muscle strength Per 1 kg
increase
20,461d 14 Regression
coefficient
0.86 (0.58 to 1.15) 1.9 × 10−9 56.4 −0.01 to 1.74 0.965 NP
Harder, 2007
[7]
Type 2 diabetes
mellitus
<2500 g vs.
≥ 2500 g
5815/
100,759
10 OR 1.32 (1.06 to 1.64) 0.013 60.8 0.71 to 2.43 0.196 NP
Harder, 2007
[7]
Type 2 diabetes
mellitus
>4000 g vs.
≤ 4000 g
6005/
108,400
9 OR 1.27 (1.01 to 1.59) 0.044 68.2 0.62 to 2.58 0.817 NP
Harder, 2008
[63]
Astrocytoma <2500 g vs.
≥ 2500 g
1574/
160,146
6 OR 0.85 (0.58 to 1.25) 0.410 31.1 0.35 to 2.09 0.931 NP
Harder, 2008
[63]
Astrocytoma >4000 g vs.
≤ 4000 g
1812/
1,649,625
8 OR 1.38 (1.07 to 1.79) 0.014 57.5 0.66 to 2.88 0.632 0.160
Harder, 2008
[63]
Medulloblastoma <2500 g vs.
≥ 2500 g
747/
158,163
5 OR 1.65 (0.42 to 6.50) 0.475 88.2 0.01 to 223 0.828a 0.503
Harder, 2008
[63]
Medulloblastoma >4000 g vs.
≤ 4000 g
853/
1,647,552
7 OR 1.28 (1.02 to 1.59) 0.033 5.6 0.90 to 1.80 0.818 NP
Harder, 2009
[64]
Type 1 diabetes
mellitus
<2500 g vs.
≥ 2500 g
5236/
1,385,809
8 OR 0.82 (0.55 to 1.24) 0.344 91.4 0.20 to 3.31 0.067 NP
Harder, 2009
[64]
Type 1 diabetes
mellitus
>4000 g vs.
≤ 4000 g
6406/
2,388,046
10 OR 1.17 (1.09 to 1.26) 1.2 × 10−5 0 1.08 to 1.28 0.883 NP
Harder, 2010
[65]
Neuroblastoma <2500 g vs.
≥ 2500 g
2907/
2,156,535
10 OR 1.24 (0.99 to 1.55) 0.058 30.2 0.74 to 2.07 0.731 NP
Harder, 2010
[65]
Neuroblastoma >4000 g vs.
≤ 4000 g
2856/
2,156,654
10 OR 1.19 (1.04 to 1.36) 0.013 0 1.01 to 1.39 0.517 NP
Jackson 2013
[66]
Pneumonia in
childhood
<2500 g vs.
≥ 2500 g
1281/1464 4 OR 3.18 (1.02 to 9.91) 0.046 95.6 0.01 to 714 0.366 NP
Kormos, 2013
[67]
Intelligence in
adolescence
<2500 g vs.
NBW
NA/NA 15 ORc 0.35 (0.27 to 0.45) 1.7 × 10−16 75.4 0.14 to 0.84 0.001a 7.8 × 10−4
Lawlor 2005
[68]
FEV1 Per 1 kg
increase
5438d 7 Regression
coefficient
0.06 (0.03 to 0.08) 1.4 × 10−5 36.5 −0.01 to 0.12 0.242 NP
Lawlor 2006
[69]
Total cholesterol
in men
Per 1 kg
increase
33,650d 34 Regression
coefficient
−0.04 (−0.07 to −0.01) 0.018 49.8 −0.15 to 0.07 0.377 NP
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Lawlor 2006
[69]
Total cholesterol in women Per 1 kg
increase
23,129d 34 Regression
coefficient
−0.01 (−0.04 to 0.02) 0.510 27.7 −0.09 to 0.07 0.686 NP
Loret de Mola,
2014 [55]
Depression in adulthood SGA vs. AGA 397/2844 5 OR 1.14 (0.64 to 2.03) 0.656 49.3 0.20 to 6.36 0.791 NP
Mebrahtu, 2015
[11]
Wheezing disorders in
childhood
<2500 g vs.
≥ 2500 g
145,421/
665,431
20 OR 1.61 (1.39 to 1.85) 1.1 × 10−10 82.3 0.92 to 2.80 0.021a NP
Mebrahtu, 2015
[11]
Wheezing disorders in
childhood
>4000 g vs.
NBW
44,988/
736,940
10 OR 1.02 (1.00 to 1.05) 0.100 0 0.99 to 1.05 0.985 NP
Michos, 2007
[70]
Testicular cancer >4000 g vs.
NBW
5684/
123,120
10 OR 1.14 (0.99 to 1.31) 0.075 42.8 0.80 to 1.62 0.791 0.006
Milne, 2013
[56]
Acute lymphoblastic
leukaemia
SGA vs. AGA 6835/
11,689
12 OR 1.24 (1.13 to 1.36) 4.9 × 10−6 0 1.12 to 1.37 0.101 NP
Mu, 2012 [71] Diastolic blood pressure <2500 g vs.
≥ 2500 g
29,192d 15 ORc 4.45 (1.32 to 14.99) 0.016 99.3 0.02 to 902 0.085a 0.001
Mu, 2012 [71] Systolic blood pressure <2500 g vs.
≥ 2500 g
32,351d 19 ORc 7.45 (2.19 to 25.33) 1.3 × 10−3 99.4 0.02 to 2296 0.148 0.615
Mu, 2014 [41]b Asthma in adulthood <2500 g vs.
≥ 2500 g
2111/
37,409
4 OR 1.25 (1.12 to 1.40) 7.7 × 10−5 0 0.98 to 1.60 0.884 NP
Øglund, 2015
[72]
Physical activity Per 1 kg
increase
10,667d 8 Regression
coefficient
−3.08 (−10.20 to 4.04) 0.397 9 −14.81 to
8.66
0.881 NP
Papadopoulou,
2012 [73]
Hodgkin lymphoma in
childhood
<2500 g vs.
NBW
669/
64,058
3 OR 0.94 (0.54 to 1.65) 0.829 0 0.03 to 35.25 0.344 NP
Papadopoulou,
2012 [73]
Non-Hodgkin lymphoma in
childhood
<2500 g vs.
NBW
1571/
68,265
5 OR 1.07 (0.71 to 1.63) 0.740 55.4 0.29 to 3.95 0.599 NP
Papadopoulou,
2012 [73]
Non-Hodgkin lymphoma in
childhood
>4000 g vs.
NBW
1615/
297,469
6 OR 1.17 (0.76 to 1.81) 0.473 66.7 0.32 to 4.28 0.085a 0.207
Panduru, 2013
[74]
Atopic dermatitis <2500 g vs.
NBW
6315/
100,663
10 OR 0.66 (0.48 to 0.90) 9.1 × 10−3 85.6 0.23 to 1.87 0.558 0.412
Panduru, 2013
[74]
Atopic dermatitis >4000 g vs.
NBW
6224/
62,672
6 OR 1.13 (0.97 to 1.31) 0.108 62.9 0.74 to 1.73 0.426 NP
Risnes, 2011
[42]b
All-cause mortality <3000 g vs.
NBW
32,926/
276,648
8 HR 1.12 (1.07 to 1.16) 6.9 × 10−8 21.7 1.03 to 1.21 0.642 NP
Risnes, 2011
[42]b
All-cause mortality >4000 g vs.
NBW
32,926/
276,648
8 HR 1.02 (0.98 to 1.05) 0.302 0 0.98 to 1.06 0.317 NP
Risnes, 2011
[42]b
All-cause mortality Per 1 kg
increase
36,834/
361,874
18 HR 0.94 (0.92 to 0.97) 2.6 × 10−6 18.6 0.89 to 0.99 0.838 0.038
Risnes, 2011
[42]b
Mortality from cardiovascular
diseases
Per 1 kg
increase
11,366/
314,715
16 HR 0.88 (0.85 to 0.91) 1.6 × 10−13 0 0.84 to 0.91 0.717 0.177
Risnes, 2011
[42]b
Mortality from cancer Per 1 kg
increase
9233/
269,944
10 HR 1.09 (1.04 to 1.14) 3.4 × 10−4 20.8 0.99 to 1.19 0.276 0.037
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Table 1 Quantitative synthesis, bias assessment and credibility assessment of 74 associations between different comparisons of birth weight and health outcomes or traits
(Continued)
Schellong, 2012
[43]b
Overweight/obese in
adulthood
<2500 g vs.
≥ 2500 g
73,420/
330,648
30 OR 0.67 (0.59 to 0.76) 1.1 × 10−9 82 0.38 to 1.18 0.079a NP
Schellong, 2012
[43]b
Overweight/obese in
adulthood
>4000 g vs.
≤ 4000 g
96,296/
396,381
45 OR 1.68 (1.58 to 1.79) 3.6 × 10−57 74.9 1.24 to 2.28 0.133 NP
Silveira 2008
[75]
Metabolic syndrome <2500 g vs.
NBW
NA/NA 11 OR 2.54 (1.57 to 4.09) 1.4 × 10−4 39.2 0.75 to 8.60 0.204 NA
Shi, 2015 [76] RSV-related acute lower
respiratory infection in
childhood
<2500 g vs.
NBW
3383/
155,872
5 OR 1.91 (1.45 to 2.53) 5.9 × 10−6 59.1 0.81 to 4.54 0.881 NP
van Montfoort,
2005 [77]
Cortisol levels Per 1 kg
increase
2301d 11 Regression
coefficient
−20.49 (−35.97 to −5.00) 9.5 × 10−3 46.3 −61.37 to
20.4
0.524 NP
Wang, 2014 [9] Coronary heart disease <2500 g vs.
≥ 2500 g
13,089/
360,209
16 OR 1.22 (1.13 to 1.31) 4.7 × 10−7 7 1.08 to 1.37 0.039a 0.751
Wang, 2014 [9] Coronary heart disease >4000 g vs.
≤ 4000 g
18,243/
313,235
14 OR 0.89 (0.81 to 0.98) 0.019 47.4 0.68 to 1.16 0.226 NP
Wang, 2014 [9] Coronary heart disease Per 1 kg
increase
NA/NA 23 OR 0.82 (0.78 to 0.86) 2.4 × 10−15 41.1 0.70 to 0.96 0.014a NA
Whincup, 2008
[78]
Type 2 diabetes mellitus Per 1 kg
increase
6090/
145,994
31 OR 0.80 (0.72 to 0.88) 1.8 × 10−5 66.5 0.52 to 1.21 0.286 0.355
White, 2009
[79]
Chronic kidney disease <2500 g vs.
NBW
NA/NA 21 OR 1.73 (1.44 to 2.08) 8.3 × 10−9 66.3 0.88 to 3.38 0.015a NA
Wojcik, 2013
[14]b
Depression in adulthood <2500 g vs.
≥ 2500 g
9013/
50,428
18 OR 1.15 (1.00 to 1.32) 0.057 34.3 0.79 to 1.67 0.171 NP
Xu, 2009 [80] Breast cancer Per 1 kg
increase
16,299/
3,604,802
16 OR 1.08 (1.03 to 1.13) 2.8 × 10−3 22.5 0.97 to 1.20 0.452 4.1 × 10−4
Yang, 2014 [12] Colorectal cancer Per 1 kg
increase
5985/
723,087
5 RR 1.05 (0.93 to 1.19) 0.461 57.1 0.72 to 1.52 0.457 0.149
Yang, 2014 [12] Endometrial cancer Per 1 kg
increase
3780/
671,410
5 RR 0.91 (0.81 to 1.03) 0.128 40.2 0.65 to 1.27 0.867 0.758
Yang, 2014 [12] Lung cancer Per 1 kg
increase
5207/
696,742
4 RR 1.09 (1.02 to 1.16) 0.016 12.3 0.90 to 1.31 0.172 0.436
Yang, 2014 [12] Melanoma Per 1 kg
increase
4000/
3,821,122
6 RR 1.14 (1.05 to 1.24) 1.9 × 10−3 0 1.01 to 1.29 0.912 NP
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Table 1 Quantitative synthesis, bias assessment and credibility assessment of 74 associations between different comparisons of birth weight and health outcomes or traits
(Continued)
Yang, 2014 [12] Non-Hodgkin lymphoma Per 1 kg
increase
2056/
626,082
3 RR 1.12 (1.01 to 1.24) 0.033 0 0.58 to 2.15 0.487 NP
Yang, 2014 [12] Ovarian cancer Per 1 kg
increase
2880/
805,887
5 RR 0.96 (0.88 to 1.04) 0.295 0 0.83 to 1.10 0.609 NP
Zhang, 2013
[81]
Diastolic blood pressure >4000 g vs.
NBW
150,980d 23 MD 0.19 (−0.23 to 0.62) 0.367 72.5 −1.39 to 1.79 0.792 NP
Zhang, 2013
[81]
Systolic blood pressure >4000 g vs.
NBW
151,935d 24 MD −0.25 (−0.92 to 0.42) 0.466 79.3 −2.97 to 2.47 0.477 NP
aBoth criteria for presence of small-study effects fulfilled (P value for Egger’s test < 0.10 and largest study with a smaller [more conservative] effect size than random-effects summary effect size)
bThe highlighted papers performed a comparison between studies adjusting for and not adjusting for gestational age
cRandom-effects summary effect size estimated from standardized mean difference transformed to odds ratio
dIn meta-analyses with a continuous outcome, the total sample size is reported
AGA adequate-for-gestational age, BMC bone mineral concentration, BMD bone mineral density, CI confidence interval, FEV1 forced expiratory volume in the first second, HR hazard ratio, OR odds ratio, RR risk ratio, MD
mean difference, NA not available, NBW normal birth weight, NP not pertinent (because the number of expected significant studies was larger than the number of observed significant studies), RSV respiratory syncytial
virus, SD standard error, SGA small-for-gestational age
Belbasis
et
al.BM
C
M
edicine
 (2016) 14:147 
Page
9
of
15
bias (acute lymphoblastic leukaemia and all types of
leukaemia), another two associations had only small-
study effects (bone tumour and non-Hodgkin lymphoma
in childhood), and two additional associations had hints
for excess significance bias (acute myeloid leukaemia
and testicular cancer).
Dose–response associations with BW
Across 28 meta-analyses, the median number of cases
was 6747 (IQR, 3945–11,326) and the median number
of datasets was 8 (IQR, 6–16). Overall, 17 associations
were significant at P < 0.05, but only six associations
survived in the application of a more stringent P value
(P < 1 × 10−6). The largest study had a standard error of
less than 0.10 in 21 meta-analyses and a more conserva-
tive effect compared to the random-effects model in 20
meta-analyses. Only six associations (all-cause mortality,
bone mineral concentration in hip, coronary heart
disease, melanoma, mortality from cardiovascular dis-
eases, and waist-to-hip ratio) presented 95 % prediction
interval excluding the null value (Table 1). Five associa-
tions presented large heterogeneity, and one association
had very large heterogeneity. Hints for small-study effects
and excess statistical significance were present in two
(bone mineral concentration in lumbar spine, coronary
heart disease) and eight meta-analyses (all-cause mortality,
acute lymphoblastic leukaemia, all types of leukaemia,
bone mineral concentration in lumbar spine, breast can-
cer, coronary heart disease, mortality from cancer, and
waist-to-hip ratio), respectively (Table 1, Additional file 2:
Table S2).
BW relative to gestational age
Three papers performed four meta-analyses examining as-
sociations between small-for-gestational-age infants (de-
fined as BW below the 10th percentile for the gestational
age) and the risk for acute lymphoblastic leukaemia, child-
hood stunting and depression. No meta-analyses on large-
for-gestational age infants were identified. Under the
random-effects model, three associations had a statistically
significant effect at P < 1 × 10−6 and 95 % prediction inter-
val excluding the null value (acute lymphoblastic leukae-
mia and childhood stunting in infants with low and
normal BW; Table 1). Only one association had large
between-study heterogeneity, whereas none of the exam-
ined associations presented evidence for small-study ef-
fects or excess significance bias.
Despite the importance of gestational age on BW, only
four out of the 36 papers (pertained to seven meta-
analyses) examining low BW, high BW or dose–response
relationships with BW, presented subgroup analyses, in-
cluding only studies that provided gestational age-
adjusted estimates (Table 1) [14, 41–43]. None of these
analyses observed a statistically significant difference in
the summary effect between the studies adjusting for
gestational age and the unadjusted studies. Additionally,
18 (46 %) papers mentioned that the observed effect
might differ from the true effect because gestational age
was not considered as an adjustment variable in several
observational studies. Twenty papers (51 %) reported the
observational studies that adjusted for gestational age in
the statistical models.
Assessment of epidemiological credibility
Twenty-eight of 78 associations (36 %) did not present a
significant summary effect at P < 0.05. Of the remaining
50 associations, only four presented convincing evidence
by having more than 1000 cases, not large heterogeneity,
95 % prediction interval excluding the null value, a sig-
nificant summary effect at P < 1 × 10−6, and absence of
small-study effects and excess significance bias (Table 2).
These associations pertained to all-cause mortality for
low versus normal BW, bone mineral concentration in
hip and mortality from cardiovascular diseases per 1 kg
increase in BW, and childhood stunting for small- versus
adequate-for-gestational-age infants with BW ≥ 2500 g.
Notably, apart from the meta-analyses on stunting,
which included gestational age in the definition of the
examined phenotype (small-for-gestational-age), none of
the other three meta-analyses with convincing evidence
restricted their analyses to studies with adjustment for
gestational age. Eleven additional associations had highly
suggestive evidence (more than 1000 cases, a significant
summary effect at P < 1 × 10−6 and largest study with a
significant effect). These associations examined perinatal
mortality in developing countries, wheezing disorders,
being overweight or obese in adulthood, coronary heart
disease for the comparison of < 2500 g versus ≥2500 g,
intelligence in adolescence for the comparison of low
BW versus normal BW, all types of leukaemia, being
overweight or obese in adulthood for the comparison
of > 4000 g versus ≤ 4000 g, muscle strength and coron-
ary heart disease for the comparison of increase per 1 kg
in BW, and maternal cardiovascular mortality and pater-
nal cardiovascular mortality for the comparison of
increase per 1 SD in BW. Fourteen associations pre-
sented suggestive evidence and 13 associations had weak
evidence (Table 2).
Discussion
Our work constitutes the first comprehensive mapping
and appraisal of the association between BW and the
risk of subsequent health outcomes, as provided by pub-
lished systematic reviews and meta-analyses of observa-
tional studies. Overall, 78 associations have been
examined, including a diverse range of outcomes: cardio-
vascular, cancer, metabolic, respiratory and mortality
outcomes, and disease traits and biomarkers. Despite
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common belief that the intrauterine environment as
assessed by BW is associated with many diseases and
disease traits in adult life [1, 6–10], our comprehensive
assessment shows that convincing evidence only exists
between the associations of low BW and increased risk
for all-cause mortality, per 1 kg increase in BW and
higher bone mineral concentration in hip and lower risk
for mortality from cardiovascular diseases. Furthermore,
the association between small-for-gestational-age and
childhood stunting in low- and middle-income countries
was supported by convincing evidence. There was no
convincing evidence supporting associations between
high BW and later outcomes; however, the associations
with overweight or obesity in later life and all types of
leukaemia were highly suggestive.
The associations between BW and cardiovascular
disease were amongst the first to be observed in the
medical literature [1–5] and our data suggests that the
Table 2 Summary of evidence grading for meta-analyses associating different contrasts of birth weight and risk of future disease
Level of
evidence
Criteria Low birth weight vs. normal
birth weight
High birth weight vs. normal
birth weight
Per unit/SD increase SGA vs. AGA
Increased risk in
LBW group
Decreased
risk in LBW
group
Increased risk in
HBW group
Decreased
risk in
HBW
group
Increased risk
per unit/SD
increase
Decreased risk
per unit/SD
increase
Increased risk in SGA
group
Convincing >1000 cases,
P < 1 × 10−6,
I2 < 50 %,
95 % PI
excluding
the null
value, no
small-study
effects and
excess sig-
nificance
bias
All-cause
mortality
None None None BMC in hip Mortality from
cardiovascular
diseases
Childhood stunting
(in BW≥ 2500 g group)
Highly
suggestive
>1000 cases,
P < 1 × 10−6,
largest study
with a
statistically
significant
effect
Perinatal
mortality in
developing
countries,
wheezing
disorders in
childhood,
coronary heart
disease
Overweight
or obese in
adulthood,
intelligence
in
adolescence
All types of
leukaemia,
overweight or
obese in
adulthood
None None Muscle
strength,
coronary heart
disease,
maternal
cardiovascular
mortality,
paternal
cardiovascular
mortality
None
Suggestive >1000 cases,
P < 1 × 10−3
Asthma in
adulthood, RSV-
related acute
lower respira-
tory infections
in childhood,
chronic kidney
disease
None Acute
lymphoblastic
leukaemia, type 1
diabetes mellitus
None BMC in
lumbar spine,
acute
lymphoblastic
leukaemia, all
types of
leukaemia,
FEV1, mortality
from cancer
Waist-to-hip
ratio, all-cause
mortality, type
2 diabetes
mellitus
Acute lymphoblastic
leukaemia
Weak The
remaining
associations
with P < 0.05
Diastolic blood
pressure,
testicular
cancer, type 2
diabetes
mellitus,
metabolic
syndrome,
pneumonia in
childhood,
school-age
asthma, systolic
blood pressure
Atopic
dermatitis
Acute myeloid
leukaemia,
astrocytoma,
medulloblastoma,
neuroblastoma,
type 2 diabetes
mellitus
Coronary
heart
disease
Breast cancer
at any age,
lung cancer,
melanoma,
non-Hodgkin
lymphoma
Cortisol levels,
total
cholesterol in
men
Childhood stunting
(in BW < 2500 g group)
AGA adequate-for-gestational age, BMC bone mineral concentration, BW birth weight, FEV1 forced expiratory volume in the first second, HBW high birth weight,
LBW low birth weight, SD standard deviation, SGA small-for-gestational age, RSV respiratory syncytial virus
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current evidence is highly suggestive. Both meta-
analyses looking at low (<2500 g) versus high (≥4000 g)
BW and those examining per 1 SD increase in BW
showed highly significant summary effects and small
between-study heterogeneity. However, both associations
presented evidence for small-study effects and the dose–
response association additionally had hints for excess
significance bias. The latter may have resulted in inflated
effect estimates for an association with cardiovascular
disease that needs cautious interpretation [35, 44]. Des-
pite the fact that studies have adjusted for a range of
confounders, including socioeconomic status, not all
studies were adjusted for gestational age, which is an im-
portant confounder and this, as well as other
unrecognized confounders, could explain the observed
association. In addition, the mechanisms underlying this
association remain unclear despite many hypotheses
having been suggested, including the one supporting that
intrauterine under-nutrition leads to fetal adaptation,
which is subsequently related to adverse cardiovascular
risk in later life [10]. However, others have provided evi-
dence that at least some of the association between the
BW of individuals and their later risk of cardiovascular
disease may be genetic and therefore not modifiable via
interventions that target the intrauterine environment
[45]. The causal pathway linking BW to cardiovascular
risk needs further elucidation to allow evidence-based
public health interventions.
The observed increased risk of cardiovascular disease
associated with lower BW is likely to be a main con-
tributor to the inverse association of BW with all-cause
mortality; an association supported by convincing evi-
dence in our assessment [42]. The higher incidence of
perinatal mortality in the low BW group is also likely
contributing to the all-cause mortality association with
low BW, but only to a small extent. Babies born with a
BW below 2500 g had increased perinatal mortality, an
association supported by a very large summary effect es-
timate and a very small P value [46]. However, the meta-
analysis on perinatal mortality was focused exclusively
on developing countries. Therefore, the effect estimate
might be exaggerated due to lack of neonatal intensive
care units or difficult access to specialized healthcare fa-
cilities in these countries [47]. These data could not be
generalised to other settings where high-quality health-
care is available.
The association between low BW and low bone
mineral concentration in later life is less well studied
compared to other outcomes and current data stem
from six studies contributing to the meta-analysis
[48]. Despite the fact that the association with bone
mineral concentration in hip showed convincing
evidence, cautious interpretation is required as data
on osteoporotic fractures has not been reviewed and
meta-analyses on other anatomical sites (e.g. lumbar
spine) showed evidence for excess significance bias
and no convincing associations.
Comparisons between BW and later overweight and
obesity do not support a detrimental health effect of low
BW. BW less than 2500 g was found to be protective for
being overweight or obese, whereas BW greater than
4000 g was linked with an increased risk for being over-
weight or obese in adult life [43]. These associations
were supported by highly suggestive evidence, but they
also displayed very large between-study heterogeneity.
Heterogeneity could be due to biased results in some of
the included studies, but it could also reflect genuine
differences across studies [35]. BW distributions are re-
markably different across developed and developing
countries [49], and the associations between BW and
later adiposity may differ in these populations, contribut-
ing to the heterogeneity of the observed results. High
BW is potentially causally associated with maternal BMI
and glucose levels [50, 51]; however, the extent to which
it could be modified through lifestyle or pharmacological
interventions merits further investigation, particularly
through long-term follow-up of interventions during
pregnancy, which will strengthen and enhance the avail-
able evidence, particularly between high BW and subse-
quent risk of childhood and adulthood obesity [52–54].
Although 29 associations focused on outcomes related to
different types of cancer, high BW was found to be a risk
factor only for developing leukaemia [13]. The associated
summary effect estimate might be inflated by the presence
of small-study effects and excess significance bias. However,
the statistical heterogeneity was not large, the 95 % predic-
tion interval excluded the null value and the association
was highly significant. Similarly, despite diabetes being cen-
tral in the “fetal origin hypothesis” [7], its association with
high and low BW has weak evidence in the literature and is
only suggestive of a direct association with high BW in line
with the obesity-associated evidence.
Despite intensive research on BW reflected by the large
number of meta-analyses identified, there were only three
papers that performed meta-analyses of studies assessing
low BW in relation to gestational age [40, 55, 56], whereas
no single meta-analysis on large-for-gestational-age neo-
nates was identified. As BW and gestational age are
highly correlated, analyses which consider size-for-
gestational-age rather than BW adjusted for gestational
age have been proposed as a more appropriate alterna-
tive [57, 58]. Among the examined phenotypes in
relation to small-for-gestational-age, the association be-
tween small-for-gestational-age without low BW and
childhood stunting in low- and middle-income coun-
tries showed convincing evidence. However, those re-
sults require cautious interpretation as the analyses
were stratified by BW and the association between
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small-for-gestational age with low BW and childhood
stunting showed a much weaker effect estimate and
was only supported by weak evidence. Additionally,
those analyses focused on low- and middle-income
countries, limiting the generalisability of those results
but at the same time also highlighting the need for in-
terventions during the pregnancy period in these popu-
lations [40]. The remaining meta-analyses included a
mixture of studies that adjusted or not their analyses for
gestational age and, hence, the current literature is incon-
clusive on the effects of BW relative to gestational age.
In the present study, we applied the umbrella review ap-
proach summarising data from already published system-
atic reviews and meta-analyses. This approach takes full
advantage of the existing meta-analyses to perform a stan-
dardised methodological process for the assessment of the
epidemiological credibility of the findings. However, our
study has some caveats. First, the Egger test and excess stat-
istical significance test offer hints of bias, and not proof
thereof, while the Egger test is difficult to interpret when
the between-study heterogeneity is large. Further, our ex-
cess significance estimates were based on the largest study
of each meta-analysis and they might be conservative, be-
cause often these studies were not necessarily very large or
might have had inherent biases themselves. Furthermore,
we did not appraise the quality of the primary studies, be-
cause this was beyond the scope of this umbrella review.
This should be the aim of the original systematic reviews
and meta-analyses, which should examine the methodo-
logical characteristics of the component studies.
Conclusions
Our study maps the current status of evidence on 78 asso-
ciations of BW with various health outcomes, traits and
biomarkers. Of them, only three examined the effects of
BW in relation to gestational age through size-at-birth de-
fined phenotypes. Our results show that the range of out-
comes associated with BW is narrow and smaller than
described under the fetal origin of disease hypothesis. Cur-
rently, there is weak evidence that BW constitutes an effective
public policy intervention for long-term health and disease.
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